Journal article
Cells of origin in osteosarcoma: Mesenchymal stem cells or osteoblast committed cells?
AJ Mutsaers, CR Walkley
Bone | Published : 2014
Abstract
Osteosarcoma is a disease with many complex genetic abnormalities but few well defined genetic drivers of tumor initiation and evolution. The disease is diagnosed and defined through the observation of malignant osteoblastic cells that produce osteoid, however the exact cell of origin for this cancer remains to be definitively defined. Evidence exists to support a mesenchymal stem cell as well as committed osteoblast precursors as the cell of origin. Increasing numbers of experimental models have begun to shed light on to the likely cell population that gives rise to OS in vivo with the weight of evidence favoring an osteoblastic population as the cell of origin. As more information is gathe..
View full abstractGrants
Funding Acknowledgements
We thank Jack Martin for ongoing discussion and comments. Work in the authors laboratory is supported by grants from the National Health and Medical Research Council of Australia (NHMRC, C.W.); Australian Sarcoma Study Group (ASSG, C.W.); Victorian Cancer Council (VCC, C.W.); OVC Pet Trust (A.M.); AACR-Aflac Inc, Career Development Award for Pediatric Cancer Research (C.W.); in part by the Victorian State Government Operational Infrastructure Support Program (to St. Vincent's Institute). C.W. is the Philip Desbrow Senior Research Fellow of the Leukaemia Foundation.